https://www.selleckchem.com/pr....oducts/necrosulfonam
71 (95%CI, 0.70-0.72), 0.88 (95%CI, 0.86-0.89), and 0.85 (95%CI, 0.82-0.88), respectively. Risk factors for all three outcomes included age, long-acting β agonist, high-dose inhaled glucocorticoid, or chronic oral glucocorticoid therapy. In subgroup analysis of 9,448 patients with spirometry data, low FEV and FEV to FVC ratio were identified as top risk factors for asthma exacerbation, ED visits, and hospitalization. However, adding pulmonary function tests did not improve models' prediction performance. Models built with an ML
Like
Comment
Share
